건성안에서의 항산화 및 염증 억제 기능성 복합식품의 효과 = The Effect of an Anti-oxidative and Anti-inflammatory Functional Dietary Supplement in Dry Eye Syndrome

다국어 초록 (Multilingual Abstract)

Purpose: To evaluate the effect of Optibiol®, which is composed of multiple anti-oxidative and anti-inflammatory dietary elements, on the symptoms, clinical manifestations, and expression of various inflammatory cytokines in dry eye patients. Methods: Patients suffering from dry eye were given Optibiol® for 3 months. They completed questionnaires regarding dry eye symptom and underwent slit lamp biomicroscopic examinations, tear film breakup times, Shirmer tests, and conjunctival fluorescein staining examinations on a monthly basis during the intake of Optibiol®. Sampling of serum and tears was conducted at baseline and 3 months after taking Optibiol®, and various inflammatory cytokines in the serum and tears were measured with multiplex bead immunoassay. Result: Sixty-three patients were included in this study. After taking Optibiol®, the dry eye symptoms, Schirmer scores, tear film breakup times, and conjunctival staining scores (Oxford scale) showed significant improvement, and the expression of most inflammatory cytokines had decreased: in particular, IL-1β and MIP-1β in serum, and IL-17 and MIP-1β in tears were significantly lower. Conclusions: Optibiol®, an anti-oxidative and anti-inflammatory functional dietary supplement, is an effective dietary supplement in patients with dry eye syndrome. We posit that the decreased expression of inflammatory cytokines is an important mechanism in this effect. J Korean Ophthalmol Soc 2008;49(9):1397-1405

참고문헌 (Reference)

1 Calder PC, "n-3 polyunsaturated fatty acids, inflammation and immunity: pouring oil on troubled waters or another fishy tale?" 21 : 309-341, 2001

2 Calder PC, "n-3 fatty acids and cardiovascular disease: evidence explained and mechanisms explored" 107 : 1-11, 2004

3 Tatlipinar S, "Topical cyiclosporin in the treatment of ocular surface disorder" 89 : 1363-1367, 2005

4 Lemp MA, "The definition and classification of dry eye disease: report of the Definition and Classification Subcom mittee of the International Dry Eye WorkShop (2007)" 5 : 75-92, 2007

5 Bron AJ, "The Doyne Lecture. Reflections on the tears" 11 : 583-602, 1997

6 Suzuki Y, "Suppressive effects of astaxanthin against rat endotoxin-induced uveitis by inhibiting the NF-kappaB signaling pathway" 82 : 275-281, 2006

7 Sherry B, "Resolution of the two components of macrophage inflammatory protein 1, and cloning and characterization of one of those components, macrophage inflammatory protein 1" 168 : 2251-2259, 1988

8 Calder PC, "Polyunsaturated fatty acids, inflammation and immunity" 36 : 1007-1024, 2001

9 Tüzün A, "Oxidative stress and antioxidant capacity in patients with inflammatory bowel disease" 35 : 569-572, 2002

10 Menten P, "Macrophage inflammatory protein-1" 13 : 455-481, 2002

11 Nakamura S, "Involvement of Oxidative Stress on Corneal Epithelial Alterations in a Blink-Suppressed Dry Eye" 48 : 1552-1558, 2007

12 Creuzot C, "Improvement of dry eye symptoms with polyunsaturated fatty acids" 29 (29): 868-873, 2006

13 Yoon KC, "Expression of Th-1 Chemokines and Chemokine Receptors on the Ocular Surface of C57BL/6 Mice: Effects of Desiccating Stress" 48 : 2561-2569, 2007

14 Snodderly DM, "Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins" 62 : 1448-1461, 1995

15 Mrugacz M, "Elevated Tear Fluid Levels of MIP-1 in Patients with Cystic Fibrosis" 27 : 491-496, 2007

16 Mrukwa-Kominek E, "Effect of anti-inflammatory therapy on the treatment of dry eye syndrome" 109 : 79-84, 2007

17 Seddon JM, "Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration" 272 : 1413-1420, 1994

18 Her J, "Clinical effects of various antiinflammatory therapies in dry eye syndrome" 47 : 1901-1910, 2006

19 Paiva SA, "Beta carotene and other carotenoids as antioxidants" 18 : 426-433, 1999

20 Stephen C, "Antiinflammatory therapy for dry eye" 137 : 337-342, 2004

21 Zhao Y, "Anti-inflammatory and anticoagulant activities of lycopene in mice" 23 : 1591-1595, 2003

22 Francisco PG, "Anti-inflamatory action of pluchea sagittalis: involvement of an antioxidant mechanism" 59 : 2033-2040, 1996

23 "Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8" 119 : 1417-1436, 2001

24 "Age-Related Eye Disease Study Research Group. A randomized, placebo controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9" 119 : 1439-1452, 2001